Rajiv Pruthi, M.D., to review management of coagulation disorders at national symposium
On Dec. 4, Mayo Clinic Laboratories will host the Friday Satellite Symposium A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis, preceding the 62nd American Society of Hematology Annual Meeting and Exposition.
During the symposium, Rajiv Pruthi, M.B.B.S., will deliver two presentations:
- "New Therapies for Hemophilia: Options and Assays"
- "Rationale Application of Next-Generation Sequencing Technologies in Coagulation Disorders"
In these presentations, Dr. Pruthi will cover current and future availability of products for hemophilia, and the laboratory assays that are used to assess the efficacy of these products. In addition, with the rapid growth of gene testing, he will explain how best to apply this technology in the diagnosis and management of coagulation disorders.
"I am excited to share the multiple options that hemophilia patients currently have and will have in the future for management of their bleeding disorders," Dr. Pruthi says.
Regarding the benefits of attending this event, Dr. Pruthi adds: "This symposium provides an opportunity for the audience to more intimately interact with the faculty, and there are sessions that meet everyone’s clinical interests."
Dr. Pruthi is a board-certified hematologist at Mayo Clinic in Rochester, Minnesota. He is director of the Mayo Comprehensive Hemophilia Center and co-director of the Special Coagulation and Molecular Hematopathology laboratories.
The symposium agenda, information about continuing education credits, and registration details are available on the event website. Registration is limited to 300 attendees. The deadline to register is Thursday, Dec. 3, at 5 p.m. CT.